George Millen: Unscripted

As Cellectar Biosciences preps its Q2 report, all eyes are on its cash runway and the immense promise of its targeted cancer therapy platform.

Sphere Entertainment's earnings show a stark divide: soaring success from its futuristic venues clashes with the steady decline of its legacy media arm.

Catalyst Acquisition Corp. has closed its $200M IPO. Led by media veterans, the SPAC is now on the hunt for a major deal in the booming gaming and media sectors.

Beyond the paycheck, a strategic shift to voluntary benefits is redefining the employer-employee contract, offering a competitive edge at no direct cost.

The firm’s rapid expansion into small-town America is more than a growth story. It’s a case study in how a founder's mission can scale into a national force.

Revive Collagen's rapid growth isn't just about beauty. Its new mushroom-collagen line is a masterclass in market disruption and strategic brand building.

DCI Group's hire of CNN veteran Kate Bennett is more than a revolving door move; it's a strategic acquisition of narrative control for the C-suite.

With Q2 earnings soaring and its outlook raised, Bunge is proving its Viterra merger was a strategic masterstroke, creating an agile giant in a volatile world.

OpenAI's new partnership with training firm Tech Leaders reveals a critical strategy: using specialized partners to bridge the vast AI adoption gap for SMBs.

A federal court ordered Papaya Gaming to pay Firy Inc. $719M for cheating players with bots. This record verdict validates Firy's business model and sets a new, costly precedent for fair play.

As GrowGeneration preps its Q2 earnings, investors are watching. Will its pivot to proprietary brands and B2B sales prove its turnaround is real?

Pluri's subsidiary Cellav just won UK approval for its aesthetic product. But the real story is the science and a market potentially 4x larger than stated.

The travel club's Q2 results reveal deep losses and cash burn from its new membership model, testing investor faith amidst geopolitical headwinds.

NextPlat declares a strategic turnaround, but the real story is its complex model: blending high-margin healthcare with niche satellite tech. Can it deliver?

As PPHC preps for its Q2 results, the strategic communications giant faces a key test. Can its aggressive M&A and strong growth narrative overcome market jitters?

Siris's sale of Equiniti isn't a clean break. We unpack the decision to retain three UK businesses, signaling a major investment in pension and lending tech.

With a 97% adoption rate, ARC's use of Suki's AI offers a rare look at a successful tech deployment that tackles burnout and boosts the bottom line.

Beam Therapeutics is set to unveil pivotal data for its AATD gene editor. Success could transform a disease and validate a multi-billion-dollar platform.

Hermeus taps finance veteran Sameer Rao, signaling a critical shift from R&D to scaling production in the high-stakes hypersonic defense market.

A new global partnership grants Amex Platinum holders elite Accor status, reshaping the competitive landscape for premium travel and loyalty rewards.